Skip to Main Content

Paper Details

Prevalence and Landscape of Actionable Genomic Alterations in Renal Cell Carcinoma.
Clin Cancer Res
8
2021
Cancer, DNA mismatch repair, DNA mismatch repair (MMR) gene, MET gene, MMR, MSK, RCC, RCC tumors, Renal Cell Carcinoma, TMB, cancer, metastatic RCC, metastatic disease, microsatellite instability, papillary, papillary RCC tumors, renal cell carcinoma, tumor, tumor samples, tumors
Author NameAffiliation
Francisco VegaMemorial Sloan Kettering Cancer Center
Jeremy C DurackMemorial Sloan Kettering Cancer Center
Stephen B SolomonMemorial Sloan Kettering Cancer Center
Victor E ReuterMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
Timothy A ChanMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Nikolaus SchultzMarie-Josee and Henry R. Kravis Center for Molecular Oncology, Memorial Sloan Kettering Cancer Center
Nikolaus SchultzMemorial Sloan Kettering Cancer Center
Abraham Ari HakimiMemorial Sloan Kettering Cancer Center
Abraham Ari HakimiMemorial Sloan Kettering Cancer Center
  • 1 - 12

Datasets

Release 1.2